Annex

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘lasalocid’ is replaced by the following:

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Lasalocid	Lasalocid A	Poultry	60 μg/kg 300 μg/kg 150 μg/kg 300 μg/kg 150 μg/kg	Muscle Liver Kidney Skin and fat in natural proportions Eggs	NO ENTRY	Anti-infectious agents/Antibiotics’
		Bovine	10 μg/kg 20 μg/kg 100 μg/kg 20 μg/kg	Muscle Fat Liver Kidney	Not for use in animals from which milk is produced for human consumption